Skip to main contentSkip to main content
You have permission to edit this article.

General, Abdominal Obesity in Middle Age Tied to Later Frailty Risk

  • 0
General, Abdominal Obesity in Middle Age Tied to Later Frailty Risk

TUESDAY, Jan. 24, 2023 (HealthDay News) -- Both general and abdominal obesity, especially over time during adulthood, is associated with an increased risk for subsequent prefrailty/frailty, according to a study published online Jan. 23 in BMJ Open.

Shreeshti Uchai, M.P.H., from the University of Oslo in Norway, and colleagues examined the association between obesity, assessed using body mass index (BMI) and waist circumference (WC), and prefrailty/frailty among 2,340 women and 2,169 men (aged 45 years or older at baseline and followed for 21 years).

The researchers found that participants with baseline obesity based on BMI were more likely to be prefrail/frail than those with normal BMI (adjusted odds ratio [aOR], 2.41), and similarly, those with high (aOR, 2.14) or moderately high (aOR, 1.57) baseline WC were more likely to be prefrail/frail than those with normal WC. There were no significantly increased odds for prefrailty/frailty among those with normal BMI at baseline but moderately high or high WC or overweight with normal WC. Having both obesity and moderately high or high WC was associated with increased odds of prefrailty/frailty. Furthermore, those in "overweight to obesity" or "increasing obesity" trajectories had higher odds of prefrailty/frailty than those with stable normal BMI, as did those with high versus stable normal WC throughout follow-up.

"Maintaining normal BMI and WC throughout adult life is important," the authors write.

Abstract/Full Text


Originally published on, part of the TownNews Content Exchange.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Cannabis dispensaries are cropping up nationwide now that marijuana is legal for medical and/or recreational use in many states.

Scientists say delivering gene therapy directly to the brain holds great promise. The first brain-delivered gene therapy on the market was recently approved in Europe and the U.K. for a rare genetic disorder called AADC deficiency. It causes developmental delays and movement disorders in kids. New Jersey drugmaker PTC Therapeutics plans to seek approval for the treatment in the U.S. this year. Meanwhile, about 30 studies in the U.S. are testing gene therapy directly to the brain for other disorders, including Alzheimer’s and Parkinson’s. Challenges remain, especially with diseases caused by more than a single gene. But scientists say the evidence supporting this approach is mounting.

Eating smaller meals and cutting calories is a more effective way to manage weight than intermittent fasting, when consumption is restricted to a narrow window of time. That’s the conclusion of researchers from Johns Hopkins University School of Medicine who studied the eating, sleeping and waking patterns of 547 adults over a six-month period.

Women's marches demanding the protection of abortion rights drew thousands of people to the streets across the country on Sunday. The day marks the 50th anniversary of Roe v. Wade, the 1973 Supreme Court decision for abortion rights that was overturned by the court last June. The main march was being held in Madison, Wisconsin. Organizers say they chose that location because of an upcoming state Supreme Court election that could determine the balance of power on the court and the future of abortion rights in Wisconsin. Abortions are unavailable in the state due to legal uncertainties faced by abortion clinics there.

Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | RSS Feed | Omny Studio

Get up-to-the-minute news sent straight to your device.



Breaking News

Huskers Breaking News

News Alert